fda compounding glp-1 warning letters september 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications FDA to Restrict Ingredients Used

When symptoms persist for more than a few weeks, medical evaluation for gastroparesis is essential and of utmost importance

This question has gained prominence as GLP-1 receptor agonistsmedications for type 2 diabetes and weight managementbecome increasingly prescribed across the UK

Safe When Supervised: Delivered with professional medical oversight, including screening and follow-up to ensure patient safety and eligibility

A relevant issue that remains controversial is whether the positive impact of GLP-1RAs on hepatic histology is indirect, i.e., through their action on the pancreas or other extrahepatic tissues, or direct, i.e., through activating GLP-1R on hepatocytes